In Nashville with a sick friend. Back Sunday.
I don’t buy it. We are bombarded by articles making all kind of things out of Dr. Insel’s blog post, Transforming Diagnosis, an announcement that the NIMH will move away from the DSM-5 – coming just a couple of weeks before the DSM-5 even goes on sale. Like everyone else, I’ve joined in on the […]
There was a time – it was a long time ago, maybe 40 years ago – when I could think whatever I wanted to think. I could use a jillion models – be doctor medical model at 8AM, psychoanalytic at 9AM, cognitive behavioral before lunch, and throw in a little existentialism in the afternoon. It […]
I had a patient long ago who was struggling to find a way to describe her Mom and why she was so conflicted about her – being both devoted to and oppressed by their relationship. She said, "She’s just crazy-making!" That phrase stuck with me and was probably the nidus for a later old saying […]
The agenda of the launch of the DSM-5 has been redirected by Dr. Insel’s Transforming Diagnosis. One example among many: The New Criteria for Mental Disorders New Yorker by Maria Konnikova May 8, 2013 … The director of the National Institute of Mental Health, Thomas Insel, announced last week that the institute would be officially […]
Maybe one would have to be an old psychiatrist to think this, but this paper is about what’s actually wrong in psychiatry right now. It’s where the problem starts – not the result of something else: Why Are Children Given Antipsychotics? Neuroskeptic May 7, 2013 Prescriptions of antipsychotic [aka neuroleptic] drugs in North American children […]
Will Male Breasts Derail A J&J Settlement Over Risperdal Marketing? Pharmalot by Ed Silverman 05/10/2013 A much-anticipated settlement of various federal government probes into Johnson & Johnson marketing of the Risperdal antipsychotic, as well as other medications, is being delayed over language the health care giant fears may cause difficulties for a raft of private […]
Dr. Bruce Cuthbert, director of NIMH’s Division of Adult Translational Research and Treatment Development. He and NIMH director Thomas Insel are leading the Research Domain Criteria Project [RDoC]. Dr. Paul Summergrad, incoming president of the American Psychiatric Association. He’s chairman of the Department of Psychiatry at Tufts University School of Medicine, and Psychiatrist-in-Chief at Tufts […]
There’s a newish blog in town: Psychology Today‘s "How Everyone Became Depressed: The rise and fall of the nervous breakdown" by Dr. Edward Shorter, medical and psychiatric historian at the University of Toronto. This week, he weighs in on the NIMH v. DSM-5 story and coming APA Meeting [with a very apt title] and also […]